Healthy Extracts Inc. — Cyborg Score 4/10

Strategic Profile

The company develops bergamot-based products (BergaMet Pro+, BergaMet Mega+O, etc.) and plant-based health technology neuro-products for brain health under brands like UBN ACTIVATE and UBN RELIEF. The company achieved strong revenue growth (up 21% year-over-year in Q3 2025) while reaching its fourth consecutive positive cash flow quarter. A transformative acquisition of Gummy USA (August 2025) was projected to generate up to $7 million in additional annualized revenue.

Cyborg Score Rationale

Healthy Extracts demonstrates solid operational traction with multiple consecutive positive cash flow quarters and strong revenue growth in 2025 (up 21-35% YoY). However, the micro-cap structure ($21M market cap as of May 2026), minimal employee base (~22 employees), and continued net losses present significant execution and scaling risks. The patented IP and subscription-based recurring revenue model offer strategic differentiation.

Top Insights

• Achieved fourth consecutive positive cash flow quarter (Q3 2025), signaling operational improvement despite small scale
• Q3 2025 net revenue reached approximately $920K (record for a quarter), up 23% YoY with 21% growth reported year-to-date
• Gummy USA acquisition (August 2025) targets material revenue expansion from $4.2M to $6.3M+ in 2025, with $7M annualized upside
• Patented oral delivery technology and subscription-based recurring revenue model differentiate from commodity supplement competitors

Named Competitors

• Charlotte's Web — Plant-based wellness products including CBD
• Nature's Way — Established herbal supplement manufacturer
• Vitafusion — Gummy vitamin and supplement brand
• Amazon Supplement Sellers (D2C) — Direct-to-consumer supplement distribution

Recent Developments

• (Q3 2025, November 2025) Reported record quarterly revenue of approximately $920K (up 23% YoY) and fourth consecutive positive cash flow quarter
• (August 2025) Acquired Gummy USA subsidiary; 2025 revenue guidance increased from $4.2M to $6.3M+ (102% growth)
• (September 2025) New CEO appointed as company positioned itself as leader in science-based nutraceuticals
• (October 2024–Q3 2025) Secured major private-label win from leading women's health direct-to-consumer Amazon seller

Open the full interactive Healthy Extracts Inc. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.